Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines
Gherardo Mazziotti, Anna Maria Formenti, Robert A. Adler, et al.
Endocrine (2016) Vol. 54, Iss. 3, pp. 603-611
Closed Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Glucocorticoid-induced osteoporosis: an update
Juliet Compston
Endocrine (2018) Vol. 61, Iss. 1, pp. 7-16
Open Access | Times Cited: 376
Controversies in Vitamin D: Summary Statement From an International Conference
Andrea Giustina, Robert A. Adler, Neil Binkley, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 104, Iss. 2, pp. 234-240
Open Access | Times Cited: 254
Consensus statement from 2nd International Conference on Controversies in Vitamin D
Andrea Giustina, Robert A. Adler, Neil Binkley, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 21, Iss. 1, pp. 89-116
Open Access | Times Cited: 240
Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development
Hanxuan Li, Zhousheng Xiao, L. Darryl Quarles, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 8, pp. 1489-1507
Open Access | Times Cited: 166
Glucocorticoid-induced osteoporosis: 2019 concise clinical review
Giovanni Adami, Kenneth G. Saag
Osteoporosis International (2019) Vol. 30, Iss. 6, pp. 1145-1156
Open Access | Times Cited: 158
Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?
John P. Bilezikian, Anna Maria Formenti, Robert A. Adler, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 4, pp. 1201-1218
Open Access | Times Cited: 123
Pituitary Diseases and Bone
Gherardo Mazziotti, Stefano Frara, Andrea Giustina
Endocrine Reviews (2018) Vol. 39, Iss. 4, pp. 440-488
Open Access | Times Cited: 149
The Immune System in Cushing’s Syndrome
Valeria Hasenmajer, Emilia Sbardella, Francesca Sciarra, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 9, pp. 655-669
Closed Access | Times Cited: 111
COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
Manel Puig‐Domingo, Mónica Marazuela, Bülent Okan Yıldız, et al.
Endocrine (2021) Vol. 72, Iss. 2, pp. 301-316
Open Access | Times Cited: 100
Osteoporosis in COPD patients: Risk factors and pulmonary rehabilitation
Yujuan Li, Hongchang Gao, Lei Zhao, et al.
The Clinical Respiratory Journal (2022) Vol. 16, Iss. 7, pp. 487-496
Open Access | Times Cited: 47
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects
Gherardo Mazziotti, Anna Maria Formenti, Stefano Frara, et al.
European Journal of Endocrinology (2017) Vol. 177, Iss. 5, pp. R231-R248
Open Access | Times Cited: 82
Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
Salvatore Minisola, Cristiana Cipriani, Giada Della Grotta, et al.
Therapeutic Advances in Musculoskeletal Disease (2019) Vol. 11
Open Access | Times Cited: 73
Comorbidity of osteoporosis and Alzheimer’s disease: Is `AKT `-ing on cellular glucose uptake the missing link?
Karin Fehsel, Julia Christl
Ageing Research Reviews (2022) Vol. 76, pp. 101592-101592
Closed Access | Times Cited: 29
New tools for bone health assessment in secreting pituitary adenomas
Meliha Melin Uygur, Stefano Frara, Luigi di Filippo, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 4, pp. 231-242
Closed Access | Times Cited: 18
A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy
Mingxiang Cai, Li Yang, Shufan Zhang, et al.
International Journal of Nanomedicine (2017) Vol. Volume 12, pp. 7469-7482
Open Access | Times Cited: 53
Advances in treatment of glucocorticoid-induced osteoporosis
Emory Hsu, Mark S. Nanes
Current Opinion in Endocrinology Diabetes and Obesity (2017) Vol. 24, Iss. 6, pp. 411-417
Open Access | Times Cited: 52
High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone–Suppressive Therapy for Thyroid Carcinoma
Gherardo Mazziotti, Anna Maria Formenti, Stefano Frara, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 103, Iss. 3, pp. 956-964
Open Access | Times Cited: 50
Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects
Francesco Tecilazich, Anna Maria Formenti, Andrea Giustina
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 4, pp. 715-727
Open Access | Times Cited: 50
Hyperprolactinemia and bone
Luigi di Filippo, Mauro Doga, Eugenia Resmini, et al.
Pituitary (2020) Vol. 23, Iss. 3, pp. 314-321
Closed Access | Times Cited: 44
Effects of Medical Treatment of Prostate Cancer on Bone Health
Anna Maria Formenti, Alberto Dalla Volta, Luigi di Filippo, et al.
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 3, pp. 135-158
Closed Access | Times Cited: 35
Hypovitaminosis D and the endocrine phenotype of COVID-19
Andrea Giustina
Endocrine (2021) Vol. 72, Iss. 1, pp. 1-11
Open Access | Times Cited: 35
Acromegaly and Bone: An Update
Andrea Giustina
Endocrinology and Metabolism (2023) Vol. 38, Iss. 6, pp. 655-666
Open Access | Times Cited: 15
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism
Justyna Kuliczkowska-Płaksej, Aleksandra Zdrojowy-Wełna, Aleksandra Jawiarczyk-Przybyłowska, et al.
Reviews in Endocrine and Metabolic Disorders (2024) Vol. 25, Iss. 3, pp. 513-539
Closed Access | Times Cited: 5
New insights into the vitamin D/PTH axis in endocrine-driven metabolic bone diseases
Luigi di Filippo, John P. Bilezikian, Ernesto Canalis, et al.
Endocrine (2024) Vol. 85, Iss. 3, pp. 1007-1019
Closed Access | Times Cited: 5
Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk
Luca Degli Esposti, Anna Girardi, Stefania Saragoni, et al.
Endocrine (2018) Vol. 64, Iss. 2, pp. 367-377
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top